Beroni Group (Beroni Group) ROCE % : -142.68% (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Beroni Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Beroni Group's annualized ROCE % for the quarter that ended in Jun. 2023 was -142.68%.

Beroni Group ROCE % Historical Data

The historical data trend for Beroni Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beroni Group ROCE % Chart

Beroni Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-17.45

-47.40

-96.25

-33.70

-97.03

Beroni Group Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial									-36.39	-19.17	-79.75	-102.96	-142.68

Beroni Group ROCE % Calculation

Beroni Group's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-5.546	/	( ( (8.519 - 2.552)	+	(7.005 - 1.541) )	/ 2 )
	=	-5.546	/	( (5.967	+	5.464)	/ 2 )
	=	-5.546	/	5.7155
	=	-97.03 %

Beroni Group's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-6.778	/	( ( (7.005 - 1.541)	+	(6.053 - 2.016) )	/ 2 )
	=	-6.778	/	( ( 5.464	+	4.037 )	/ 2 )
	=	-6.778	/	4.7505
	=	-142.68 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Beroni Group (OTCPK:BNIGF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Beroni Group ROCE % Related Terms

Thank you for viewing the detailed overview of Beroni Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beroni Group (Beroni Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Beroni Group Ltd (OTCPK:BNIGF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhong Bei High Technology Industrial Park, Level 10, Building 11, Xiqing District, Tianjin, CHN, 300380

Website

https://www.beronigroup.com

Beroni Group Ltd is an Australia based company engaged in the sale of smoking control product (NicoBloc), air purifier, healthcare products and supplements, cosmetics and stem-cell therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Its operating segment includes Nicobloc, Fogibloc air purifier, Olansi water filter, Health supplements, Cosmetic products, Viral diagnostic kits, and Technical advisory service. Geographically, it operates in China and Japan. The highest revenue is generated from the Nicobloc segment through the China region.